| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/13/2008 | WO2007126810A3 High titer recombinant influenza viruses for vaccines |
| 03/13/2008 | WO2007124312A3 Isolated polynucleotide molecules corresponding to mutant and wild-type alleles of the maize d9 gene and methods of use |
| 03/13/2008 | WO2007113001A3 Novel brachyspira pilosicoli genes and proteins and uses thereof |
| 03/13/2008 | WO2007111714A3 Il-21 antagonists |
| 03/13/2008 | WO2007104789A3 Amylin derivatives |
| 03/13/2008 | WO2007098198A3 Modulation of bone formation |
| 03/13/2008 | WO2007073505A3 Trpa1 inhibitors for treating pain |
| 03/13/2008 | WO2007064917A3 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins |
| 03/13/2008 | WO2007047998A3 Mutations and polymorphisms of hdac2 |
| 03/13/2008 | US20080066200 Transgenic plant which serves as bioreactor for expression of humanized glycoproteins with reduced fucose and xylose residues |
| 03/13/2008 | US20080066198 Modulation of Flowering Time and Growth Cessation in Perennial Plants |
| 03/13/2008 | US20080066195 Taste Receptors of the T1r Family Form Domestic Cat |
| 03/13/2008 | US20080065207 Self-Assembling, Collagen-Based Material for Corneal Replacement |
| 03/13/2008 | US20080064859 Recombinant MHC molecules useful for manipulation of antigen-specific T-cells |
| 03/13/2008 | US20080064857 Immunoglobulin for use in diagnosis, prevention and treatment of metabolic disorders of pancreas |
| 03/13/2008 | US20080064856 Using liquid formulation of freeze dried powder comprising antibodies and antihemophilic factor as tool in enhancement of shelf-life of protein |
| 03/13/2008 | US20080064855 Modified hemoglobin with allosteric effector conjugated |
| 03/13/2008 | US20080064853 Nervous system protein for use in treatment and prevention of nervous system and seizure disorders |
| 03/13/2008 | US20080064764 Isolated nucleic acids; antibody for selective binding; biodrug treating osteoporosis, osteoblast, bone disorders, osteocalcin mediated disorder |
| 03/13/2008 | US20080064660 Modulation of Inflammation Related to Columnar Epithelia |
| 03/13/2008 | US20080064651 A 21-base antisense oligonucleotide which inhibits gene expression of testosterone-repressed prostate message-2 by tumor cells; prostate and renal cell cancer; enhanced chemosensitivity, hormone and radiation sensitivities |
| 03/13/2008 | US20080064649 Anticarcinogenic and antiproliferative agents in combination with radiation therapy, chemotherapy, ablative surgery, or partially ablative surgery for bone and breast cancer treatments |
| 03/13/2008 | US20080064648 Methods and Compositions Relating to Lipid Accumulation |
| 03/13/2008 | US20080064647 A polyvalent multimeric complex formed from a plurality of circularly permuted chimeric pRNA molecules, each carrying a stabilized biologically active moiety; degradation resistant stabilized ribozyme is correctly folded such that it remains intracellularly active |
| 03/13/2008 | US20080064641 Thr-ala-leu-arg-ile-arg-ala-thr-tyr-gly-glu-tyr, a fragment of the gamma 2 chain of laminin 5, has high biopermeability therough the epidermis and increases cellular adhesion; increases skin aging and wrinkle resistance, elasticity, healing, vascularization; cosmetics |
| 03/13/2008 | US20080064639 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis |
| 03/13/2008 | US20080064638 Proteins related to schizophrenia and uses thereof |
| 03/13/2008 | US20080064637 Before cardiopulmonary bypass surgery or coronary artery bypass grafting; injecting a polypeptide preferential inhibitor of kallikrein, rather than aprotinin |
| 03/13/2008 | US20080064633 Preventing fibronectin deposition and fibrosis; phospholipase A2 inhibition; cystic fibrosis |
| 03/13/2008 | US20080064606 Selectively binds with absolute control over orientation and density without requiring prior synthetic modification or purification to make a stable protein chip; rapid and irreversible; assaying kinase or protease activity |
| 03/13/2008 | US20080064599 Transforming a cell with the Arabidopsis thaliana-derived deformylase gene, contacting the cell with actinonin to induce herbicide resistance, plant regeneration; selectively growing the herbicide resistant plant so actinonin can be applied |
| 03/13/2008 | US20080064104 Antagonists and agonists of ldcam and methods of use |
| 03/13/2008 | US20080064102 Transiently immortalized cells for use in gene therapy |
| 03/13/2008 | US20080064097 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 03/13/2008 | US20080064096 Isolated nucleic acid molecules which encode a soluble IL-TIF receptor or binding protein which binds to IL-TIF/IL-22, and uses thereof |
| 03/13/2008 | US20080064095 Method for obtaining mastocyte lines from pig tissues and for producing heparin-type modules |
| 03/13/2008 | US20080064094 Polynucleotides encoding two novel human G-protein coupled receptors, HGPRBMY28 and HGPRBMY29, and splice variants thereof |
| 03/13/2008 | US20080064092 Single chain polypeptide fusion comprising non-cytotoxic protease and proteinase activated receptor ligands (PAR1) domains for use in treatment and prevention of allergies, respiratory system, arthritic, skin and fibrotic disorders |
| 03/13/2008 | US20080064084 Method For Producing Recombinant Trypsin |
| 03/13/2008 | US20080064083 Expression vector comprising bacterial nucleotide sequences for use in diagnosis, prevention and treatment of microorganismal infection |
| 03/13/2008 | US20080064082 Control of function of intracellular Ca ion |
| 03/13/2008 | US20080064081 Reducing antigenicity of viral protein via amino acid sequence variation; enhancing vector transferability during gene therapy |
| 03/13/2008 | US20080064074 Expression vector comprising nucleotide sequences coding decaprenyl diphosphate synthase for use in transformation and propagation of escherichia with enhanced coenzyme concentrations; cosmetics; nutraceuticals |
| 03/13/2008 | US20080064067 Corynebacterium glutamicum genes encoding phosphoenolpyruvate: sugar phosphotransferase system proteins |
| 03/13/2008 | US20080064066 Modified human granulocyte-colony stimulating factor and process for producing same |
| 03/13/2008 | US20080064060 Major histocompatibility complex proteins for use in tissue targeted therapy of tumor antigens; diagnosing organ transplant rejection |
| 03/13/2008 | US20080064054 Substrate for accurate monitoring/determining presence or absence of clostridial toxin |
| 03/13/2008 | US20080064050 Applications of the binding interaction of proanthocyanidins with bacteria and bacterial components |
| 03/13/2008 | US20080064045 Biomarker fragments for the detection of human BNP |
| 03/13/2008 | US20080063663 immunizing a cat with vaccine against a hemorrhagic feline calicivirus (hFCV); veterinary medicine |
| 03/13/2008 | US20080063662 Vaccine |
| 03/13/2008 | US20080063655 nucleic acid sequences encoding a 30 kD Brachyspira hyodysenteriae lipoprotein; host cell; new locus comprising four genes has now surprisingly been found; swine dysentery |
| 03/13/2008 | US20080063653 vector-based vaccine may well aid in the development of effective vaccines for a range of human cancers; nucleic acid; agonist polypeptide derived from a mucin tumor antigen; genetic vaccine |
| 03/13/2008 | US20080063651 therapeutic protein comprising a tenth domain of fibronectin type III; protein scaffold; antibody design; scaffold derived from a fibronectin type III (Fn3) or Fn3-like domain, function like natural or engineered antibodies; antibody mimics designed for optimal folding, stability, and solubility |
| 03/13/2008 | US20080063643 HLA-binding motif in its sequence; recognized by an HLA-A2- or HLA-A24-restricted cytotoxic T cell; nucleotide; antibody; vector; diagnosid and prognosis of hepatitis C virus infection |
| 03/13/2008 | US20080063634 genetic engineered antibody or antigen binding segment that is capable of binding to interleukins and altering the conformation structure, used for treating diseases involving immune and inflammatory responses |
| 03/13/2008 | US20080063630 polynucleotides that code for polypeptides having activity for targeting heterogeneous polypeptides to the surfaces of cytoplasmic membranes, useful for analysis of proteind, delivery of cells expressing the polypeptide to a target site in vivo, preparation of an antibodies and vaccines, and gene therapy |
| 03/13/2008 | US20080063623 adjuvants comprising proteins, polynucleotides, or genetic vectors and carriers |
| 03/13/2008 | US20080063600 use of deactivated lymphocytes, antibodies, drug mixtures and adjuvants, for the treatment or prevention of Cruetzfield-Jacobs disease in humans or animals; immunology; bioassays |
| 03/13/2008 | DE112004002217T5 Proteinbildungskomplex mit einem c-Jun-Protein, Nucleinsäure, codierend denselben und Verfahren unter Verwendung desselben The same protein complex formation with a c-Jun protein, nucleic acid encoding the same and methods using |
| 03/13/2008 | CA2663083A1 Modified human plasma polypeptide or fc scaffolds and their uses |
| 03/13/2008 | CA2663047A1 Therapeutic elastin-like polypeptide (elp) fusion proteins |
| 03/13/2008 | CA2662863A1 Methods and compositions for the detection of protein folding disorders |
| 03/13/2008 | CA2662723A1 Means and methods for the production of amyloid oligomers |
| 03/13/2008 | CA2662707A1 Split-core-particles for the presentation of foreign molecules, especially for vaccine applications, and method for their production |
| 03/13/2008 | CA2662550A1 Potent immunostimulatory component in microalgae extract |
| 03/13/2008 | CA2662453A1 Aquaretic and natriuretic polypeptides lacking vasodilatory activity |
| 03/13/2008 | CA2662439A1 Compounds as aptamer-dimers and their uses in diagnosis and therapy |
| 03/13/2008 | CA2662350A1 Antibodies to bone morphogenic proteins and receptors therefor and methods for their use |
| 03/13/2008 | CA2662323A1 Assay for antibodies to mycobacterium paratuberculosis |
| 03/13/2008 | CA2662308A1 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| 03/13/2008 | CA2662226A1 Fully human high yield production system for improved antibodies and proteins |
| 03/13/2008 | CA2662041A1 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders |
| 03/13/2008 | CA2661923A1 Methods for blocking the interaction between nkp80 and its ligand aicl |
| 03/13/2008 | CA2661634A1 Selectively targeted antimicrobial peptides and the use thereof |
| 03/13/2008 | CA2654283A1 Methods of diagnosing and treating complications of pregnancy |
| 03/12/2008 | EP1897950A2 Human GIL-19/AE289 proteins and polynucleotides encoding same |
| 03/12/2008 | EP1897949A2 Human interleukin-B50. Therapeutic uses |
| 03/12/2008 | EP1897948A1 Mammalian transforming growth factor beta 9 |
| 03/12/2008 | EP1897947A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897946A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897945A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897944A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897943A2 IL-17 homologous polypeptides and therapeutic uses thereof |
| 03/12/2008 | EP1897889A2 Method of modulating the profileration of medullary thyroid carcinoma cells |
| 03/12/2008 | EP1897888A1 Peptides binding the TPO receptor |
| 03/12/2008 | EP1897887A1 Split-core-particles for the presentation of foreign molecules, especially for vaccination purposes and methods for their preparation |
| 03/12/2008 | EP1897886A1 Compounds as aptamer-dimers and their uses in diagnosis and therapy |
| 03/12/2008 | EP1897556A1 Prevention and treatment of hypergastrinemia |
| 03/12/2008 | EP1897553A1 Inhibitor of stem cell proliferation and uses thereof |
| 03/12/2008 | EP1897552A1 Polymer-conjugated glycosylated neublastin |
| 03/12/2008 | EP1897548A1 T cell regulation |
| 03/12/2008 | EP1897536A1 Surface cross-linked lipidic particles, methods of production and uses therefor |
| 03/12/2008 | EP1897441A1 TGF-alpha polypeptides, functional fragments and methods of use therefor |
| 03/12/2008 | EP1896855A2 Biomarkers for breast cancer |
| 03/12/2008 | EP1896605A2 Stimulation of pancreatic b cell proliferation |
| 03/12/2008 | EP1896603A2 Biosynthetic process for the preparation of gallidermin |
| 03/12/2008 | EP1896591A2 Gene expression technique |
| 03/12/2008 | EP1896589A2 Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy |
| 03/12/2008 | EP1896588A1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF |